Fund Holdings — ACUTA CAPITAL PARTNERS, LLC

Total Portfolio Value:
$177.63M
Total Bought:
$84.67M
Total Sold:
$52.05M
Net Transaction:
+$32.62M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Rayzebio Inc344,571378,069+33,498$7.65M$23.50M13.23%+$15.86M
Cymabay Therapeutics Inc418,000492,155+74,155$6.23M$11.62M6.54%+$5.39M
Rocket Pharmaceuticals, Inc.(RCKT)362,000366,015+4,015$7.42M$10.97M6.18%+$3.55M
Kura Oncology, Inc.(KURA)702,093701,349-744$6.40M$10.09M5.68%+$3.68M
EyePoint, Inc.(EYPT)300,128425,128+125,000$2.40M$9.82M5.53%+$7.43M
Vaxcyte, Inc.(PCVX)121,022117,373-3,649$6.17M$7.37M4.15%+$1.20M
Sarepta Therapeutics, Inc.(SRPT)15,50070,600+55,100$1.88M$6.81M3.83%+$4.93M
Praxis Precision Medicines, Inc.(PRAX)0299,636+299,636$0$6.68M3.76%+$6.68M
Disc Medicine, Inc.(IRON)138,198115,500-22,698$6.49M$6.67M3.76%+$178.7K
Taysha Gene Therapies, Inc.(TSHA)3,827,9263,589,333-238,593$12.10M$6.35M3.58%-$5.74M
Viridian Therapeutics, Inc.(VRDN)224,339281,500+57,161$3.44M$6.13M3.45%+$2.69M
Tourmaline Bio Inc.0231,882+231,882$0$6.07M3.42%+$6.07M
Ocular Therapeutix, Inc.(OCUL)01,310,000+1,310,000$0$5.84M3.29%+$5.84M
Mersana Therapeutics Inc99,6072,368,000+2,268,393$126.5K$5.49M3.09%+$5.37M
Hillevax Inc270,319324,600+54,281$3.64M$5.21M2.93%+$1.57M
Immunovant, Inc.(IMVT)129,000119,489-9,511$4.95M$5.03M2.83%+$81.8K
Revolution Medicines, Inc.(RVMD)0160,000+160,000$0$4.59M2.58%+$4.59M
Apellis Pharmaceuticals Inc
COM
244,48476,100-168,384$9.30M$4.56M2.56%-$4.74M
Arcellx Inc
COMMON STOCK
077,000+77,000$0$4.27M2.41%+$4.27M
Whitehawk Therapeutics, Inc.(WHWK)1,849,4021,849,4020$8.95M$3.74M2.10%-$5.22M
Terns Pharmaceuticals Inc555,260555,2600$2.79M$3.60M2.03%+$810.7K
Crinetics Pharmaceuticals In94,00087,500-6,500$2.80M$3.11M1.75%+$317.7K
Celldex Therapeutics, Inc.(CLDX)122,34169,400-52,941$3.37M$2.75M1.55%-$614.4K
An2 Therapeutics Inc13,300132,000+118,700$213.9K$2.70M1.52%+$2.49M
Dyne Therapeutics, Inc.(DYN)146,500147,836+1,336$1.31M$1.97M1.11%+$653.6K
Verastem, Inc.(VSTM)230,000232,249+2,249$1.87M$1.89M1.06%+$20.6K
Applied Therapeutics Inc0525,100+525,100$0$1.76M0.99%+$1.76M
Enliven Therapeutics Inc103,600123,876+20,276$1.42M$1.71M0.97%+$299.3K
4d Molecular Therapeutics Inc074,500+74,500$0$1.51M0.85%+$1.51M
Cypherpunk Technologies Inc.(CYPH)354,166354,1660$488.7K$1.47M0.83%+$979.3K
Cellectar Biosciences, Inc.(CLRB)121,300477,500+356,200$320.2K$1.32M0.74%+$1.00M
Insmed Incorporated(INSM)029,500+29,500$0$914.2K0.51%+$914.2K
argenx SEADR(ARGX)02,400+2,400$0$913.0K0.51%+$913.0K
Verona Pharma PlcADS019,000+19,000$0$377.7K0.21%+$377.7K
Springworks Therapeutics Inc010,000+10,000$0$365.0K0.21%+$365.0K
Centessa Pharmaceuticals PlcADS323,34938,138-285,211$2.09M$303.6K0.17%-$1.79M
Tyra Biosciences, Inc.(TYRA)08,867+8,867$0$122.8K0.07%+$122.8K
Nuvation Bio Inc.W EXP 07 07 2027(NUVB)90,83290,8320$9.1K$5.5K0.00%-$3.6K
89BIO INCCOM32,8000-32,800$506.4K$0—-$506.4K
ACLARIS THERAPEUTICSCOM(ACRS)121,6920-121,692$833.6K$0—-$833.6K
ALKERMES PLCSHS(ALKS)126,5000-126,500$3.54M$0—-$3.54M
BIOMEA FUSION INCCOM(BMEA)39,9350-39,935$549.5K$0—-$549.5K
GLYCOMIMETIC INCCOM27,5000-27,500$41.3K$0—-$41.3K
IKENA ONCOLOGY INCCOM551,0100-551,010$2.39M$0—-$2.39M
IONIS PHARMACEUTICALS INCCOM(IONS)11,3000-11,300$512.6K$0—-$512.6K
KRONOS BIO INCCOM718,7390-718,739$934.4K$0—-$934.4K
MARINUS PHARMECEUTICALS INCCOM NEW19,5000-19,500$157.0K$0—-$157.0K
OLEMA PHARMACEUTICALS INCCOM(OLMA)153,0070-153,007$1.89M$0—-$1.89M
PRAXIS PRECISION MEDICINES ICOM4,485,0000-4,485,000$7.67M$0—-$7.67M
REPLIMUNE GROUP INCCOM(REPL)150,0000-150,000$2.57M$0—-$2.57M
REZOLUTE INCCOM NEW(RZLT)310,0000-310,000$409.2K$0—-$409.2K
STRUCTURE THERAPEUTICS INCSPONSORED ADS5,0000-5,000$252.1K$0—-$252.1K
SYNDAX PHARMACEUTICALS INCCOM(SNDX)297,0350-297,035$4.31M$0—-$4.31M
VENTYX BIOSCIENCES INCCOM205,3770-205,377$7.13M$0—-$7.13M
Page 1 of 1
ACUTA CAPITAL PARTNERS, LLC — 13F Holdings — Q4 2023 | TickerTrail